The autoimmune Drugs Market was valued at $109,834 million in 2021 and is projected to reach $153,321 million by 2028, registering a CAGR of 4.3% from 2022 to 2028. The immune system protects the body from the infections and diseases. In autoimmune disorders low or overactivity may appear. There is no exact causes of autoimmune diseases are identified. In response to unknown trigger, immune system produces antibodies that instead of fighting infections, attacks body own tissues. There are more than 80 autoimmune diseases are there and diagnosis varies from disease to disease based on the type of disease.Global Autoimmune Drugs market is driven by government initiatives towards increasing awareness in public about autoimmune disorders. In addition, increase in R&D investments and rising prevalence of autoimmune disorders are expected to boost the global autoimmune disease diagnostics market over the forecast period. Lack of standard treatment options, stringent regulatory framework may hinder the market for Autoimmune Drugs market globally.Market players are collaborating in order to develop the new molecules for the autoimmune diseases and further increasing their market portfolio. Furthermore, government and non-profit organizations are taking initiatives to increase the awareness and involving in development of drugs for autoimmune diseases.